Biotech News

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Outset Medical (OM)Outset Medical2026-06-25 13:46 ESTCompany update

SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of

Open original release

Related news

OMOutset Medical2026-06-25 13:46 EST

Outset Medical to Present at RBC Global Healthcare Conference

OMOutset Medical2026-06-25 13:46 EST

Outset Medical Reports First-Quarter Results

OMOutset Medical2026-06-25 13:46 EST

New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System

OMOutset Medical2026-06-25 13:46 EST

Outset Medical Reports Third-Quarter Results

OMOutset Medical2026-06-25 13:46 EST

Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

OMOutset Medical2026-06-25 13:46 EST

Outset Medical Reports Unaudited Fourth Quarter and 2025 Results

OMOutset Medical2026-06-25 13:46 EST

Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026

OMOutset Medical2026-06-25 13:46 EST

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

OMOutset Medical2026-06-25 13:46 EST

Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results

OMOutset Medical2026-06-25 13:46 EST

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

View all latest news

Outset Medical

Outset Medical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.

Recent company news

OMOutset Medical2026-06-26 09:24 EST

Outset Medical to Present at RBC Global Healthcare Conference

OMOutset Medical2026-06-26 09:24 EST

Outset Medical Reports First-Quarter Results

OMOutset Medical2026-06-26 09:24 EST

New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System

OMOutset Medical2026-06-26 09:24 EST

Outset Medical Reports Third-Quarter Results

OMOutset Medical2026-06-26 09:24 EST

Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States